Adalimumab
Biologic · tier A · 8 trials (1 recruiting) · 14 publications · score 80.0
Azathioprine
Drug · tier A · 8 trials (1 recruiting) · 18 publications · score 80.0
Meloxicam
Drug · tier A · 8 trials (0 recruiting) · 11 publications · score 80.0
Naproxen
Drug · tier A · 8 trials (0 recruiting) · 11 publications · score 80.0
Leflunomide
Drug · tier A · 8 trials (1 recruiting) · 14 publications · score 79.5
Methotrexate
Drug · tier A · 8 trials (0 recruiting) · 14 publications · score 79.0
Prednisone
Drug · tier A · 8 trials (1 recruiting) · 14 publications · score 79.0
Tocilizumab
Biologic · tier A · 8 trials (0 recruiting) · 13 publications · score 78.0
Celecoxib
Drug · tier A · 8 trials (0 recruiting) · 14 publications · score 75.5
Infliximab
Biologic · tier A · 8 trials (0 recruiting) · 15 publications · score 75.5
Abatacept
Biologic · tier A · 8 trials (0 recruiting) · 14 publications · score 74.5
Etanercept
Biologic · tier A · 8 trials (1 recruiting) · 13 publications · score 74.0
Sarilumab
Biologic · tier A · 8 trials (0 recruiting) · 16 publications · score 72.5
Anakinra
Biologic · tier A · 8 trials (0 recruiting) · 14 publications · score 71.5
Rituximab
Biologic · tier A · 8 trials (0 recruiting) · 15 publications · score 71.0
Diclofenac Sodium
Drug · tier A · 8 trials (0 recruiting) · 7 publications · score 66.5
Naproxen Sodium
Drug · tier A · 8 trials (0 recruiting) · 5 publications · score 60.0
Etodolac
Drug · tier A · 1 trials (0 recruiting) · 11 publications · score 52.5
Dexamethasone
Drug · tier A · 6 trials (1 recruiting) · 7 publications · score 51.0
Auranofin
Drug · tier A · 0 trials (0 recruiting) · 14 publications · score 50.0
Indomethacin
Drug · tier A · 0 trials (0 recruiting) · 10 publications · score 50.0
Piroxicam
Drug · tier A · 0 trials (0 recruiting) · 10 publications · score 50.0
Tacrolimus Anhydrous
Drug · tier A · 8 trials (0 recruiting) · 0 publications · score 50.0
Tofacitinib Citrate
Drug · tier A · 8 trials (1 recruiting) · 0 publications · score 46.0
Esomeprazole Magnesium
Drug · tier A · 0 trials (0 recruiting) · 2 publications · score 24.0
Research map, not treatment advice. Built 2026-10-07.